Yatharth Hospital and Trauma Care Services Limited (IN:YATHARTH)
:YATHARTH
Want to see IN:YATHARTH full AI Analyst Report?
Top Page
Yatharth Hospital and Trauma Care Services Limited
(YATHARTH)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹889.00
▲(27.04% Upside)
Action:DowngradedDate:11/30/25
Yatharth Hospital's strong financial performance, characterized by revenue growth and improved profitability, is the most significant factor driving the stock score. However, technical indicators suggest short-term bearish momentum, and the high P/E ratio points to potential overvaluation. The absence of earnings call insights and corporate events limits the analysis to these core components.
Positive Factors
Strong revenue growth
Sustained ~32% revenue growth indicates expanding patient volumes and service adoption across the hospital network. Over a multi-month horizon this supports scale benefits, stronger bargaining with payors and suppliers, and a larger base to convert operational improvements into durable profit expansion.
Negative Factors
Negative free cash flow from capex
Persistent negative free cash flow driven by elevated capital spending can strain liquidity and necessitate external financing. Over several months this reduces optionality for discretionary investments and raises execution risk if cash generation does not catch up with ongoing capex commitments.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained ~32% revenue growth indicates expanding patient volumes and service adoption across the hospital network. Over a multi-month horizon this supports scale benefits, stronger bargaining with payors and suppliers, and a larger base to convert operational improvements into durable profit expansion.
Read all positive factors
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹78.94B
Dividend YieldN/A
Average Volume (3M)28.98K
Price to Earnings (P/E)36.2
Beta (1Y)1.26
Revenue Growth31.82%
EPS Growth17.54%
CountryIN
Employees3,607
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)16.74
Shares Outstanding96,354,355
10 Day Avg. Volume38,534
30 Day Avg. Volume28,985
Financial Highlights & Ratios
PEG Ratio15.52
Price to Book (P/B)2.27
Price to Sales (P/S)4.14
P/FCF Ratio-22.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)26.84
Revenue Forecast (FY)₹16.24B
Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model
Company Description
Yatharth Hospital & Trauma Care Services Limited owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of gynecology; gastroenterology; pulmonology; pediatric; nephrology and urology; car...
How the Company Makes Money
YATHARTH primarily makes money by delivering hospital-based healthcare services and charging patients (or their payors) for clinical care and related hospital services. Key revenue streams typically include: (1) Inpatient services: room/bed charge...
Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.88B | 8.80B | 6.71B | 5.20B | 4.01B | 2.29B |
| Gross Profit | 6.73B | 5.39B | 5.37B | 4.27B | 3.20B | 1.82B |
| EBITDA | 2.69B | 2.36B | 1.96B | 1.37B | 1.13B | 675.27M |
| Net Income | 1.52B | 1.31B | 1.14B | 657.68M | 441.62M | 181.60M |
Balance Sheet | ||||||
| Total Assets | 18.56B | 17.31B | 10.19B | 4.86B | 4.26B | 3.09B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 5.15B | 2.39B | 382.36M | 120.31M | 51.52M |
| Total Debt | 262.33M | 115.86M | 846.47M | 2.67B | 2.64B | 1.93B |
| Total Liabilities | 1.36B | 940.45M | 1.45B | 3.03B | 3.09B | 2.28B |
| Stockholders Equity | 16.89B | 16.05B | 8.74B | 1.83B | 1.17B | 724.55M |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -1.61B | -964.43M | 439.70M | 468.01M | 235.38M |
| Operating Cash Flow | 485.14M | 1.50B | -30.78M | 637.84M | 599.35M | 436.73M |
| Investing Cash Flow | -2.51B | -4.20B | -2.26B | -203.10M | -521.75M | -212.38M |
| Financing Cash Flow | 142.57M | 5.19B | 3.04B | -177.48M | -11.24M | -190.50M |
Yatharth Hospital and Trauma Care Services Limited Technical Analysis
Positive
699.80
Price Trends
678.99
Positive
676.61
Positive
698.15
Positive
Market Momentum
26.35
Negative
63.25
Neutral
80.74
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 699.8 is above the 20-day moving average (MA) of 685.95, above the 50-day MA of 678.99, and above the 200-day MA of 698.15, indicating a bullish trend. The MACD of 26.35 indicates Negative momentum. The RSI at 63.25 is Neutral, neither overbought nor oversold. The STOCH value of 80.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.
Yatharth Hospital and Trauma Care Services Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹85.48B | -247.47 | ― | ― | 16.15% | -67.50% | |
66 Neutral | ₹78.94B | 36.23 | ― | ― | 31.82% | 17.54% | |
65 Neutral | ₹266.51B | 114.01 | ― | ― | 26.29% | -13.63% | |
64 Neutral | ₹36.93B | 25.06 | ― | 0.96% | 8.53% | 21.02% | |
63 Neutral | ₹363.41B | 88.98 | ― | 0.84% | 12.20% | -93.03% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ₹17.32B | 310.39 | ― | 0.59% | 4.93% | -75.50% |
* Healthcare Sector Average
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
819.30
344.50
72.56%
IN:ASTERDM
Aster DM Healthcare Ltd.
701.40
177.67
33.92%
IN:HCG
HealthCare Global Enterprises Ltd.
572.55
-15.07
-2.56%
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
402.80
9.47
2.41%
IN:KIMS
Krishna Institute of Medical Sciences Limited
666.05
5.15
0.78%
IN:SHALBY
Shalby Ltd.
160.35
-25.90
-13.91%
Yatharth Hospital and Trauma Care Services Limited Corporate Events
Yatharth Hospital Updates Key Executives Authorized to Determine Material Disclosures
Feb 25, 2026
Yatharth Hospital and Trauma Care Services has updated its list of key managerial and senior management personnel authorized to determine the materiality of events and information for stock exchange disclosures. The newly designated officials, led...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.